Nuclera closes $75 million USD financing

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million).

Inside the hospital gardens that give respite from a world of ills

WILLOWBROOK, Calif. — In this neighborhood just north of Compton, Martin Luther King Jr. Community Hospital catches the light. Tall, sleek, all windows and silver

July 24, 2023

Global burden of diabetes: new study reveals alarming prevalence and projections for 2050

Comprehensive estimates of diabetes prevalence and burden worldwide.

July 18, 2023

PharmaDrug’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – May 15, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.